tradingkey.logo
tradingkey.logo
Search

Phibro Animal Health Corp

PAHC
Add to Watchlist
34.370USD
-1.780-4.92%
Close 05/15, 16:00ETQuotes delayed by 15 min
1.39BMarket Cap
14.63P/E TTM

Phibro Animal Health Corp

34.370
-1.780-4.92%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-4.92%

5 Days

-14.07%

1 Month

-36.21%

6 Months

-23.79%

Year to Date

-8.00%

1 Year

+43.21%

Key Insights

Phibro Animal Health Corp's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 47 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 49.50.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Phibro Animal Health Corp's Score

Industry at a Glance

Industry Ranking
47 / 155
Overall Ranking
128 / 4482
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Phibro Animal Health Corp Highlights

StrengthsRisks
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 32.55% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.30B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 40.30%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 40.30%.
Undervalued
The company’s latest PE is 14.63, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 22.03M shares, decreasing 2.85% quarter-over-quarter.
Held by Paul Tudor Jones
Star Investor Paul Tudor Jones holds 10.22K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.64.

Analyst Rating

Based on 5 analysts
Hold
Current Rating
49.500
Target Price
+40.39%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Phibro Animal Health Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Phibro Animal Health Corp Info

Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Ticker SymbolPAHC
CompanyPhibro Animal Health Corp
CEOBendheim (Jack C)
Websitehttps://www.pahc.com/
KeyAI